Drug shortage
Micafungin Sodium Injection · Par Health, USA LLC
FDA drug shortage · To Be Discontinued · updated Sep 11, 2026
Key facts
| Generic name | Micafungin Sodium Injection |
|---|---|
| Company | Par Health, USA LLC |
| Presentation | Micafungin Sodium, Injection, 10 mg/1 mL (NDC 42023-229-10) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Anti-Infective |
| Package NDCs | 42023-229-10 |
| First posted | Sep 11, 2026 |
| Last updated | Sep 11, 2026 |
| Discontinued | Sep 11, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: